Lv7
3885 积分 2021-03-26 加入
The recent developments of camptothecin and its derivatives as potential anti-tumor agents
10天前
已完结
Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy
10天前
已完结
The Potential Clinical Relevance of Visible Particles in Parenteral Drugs
11天前
已完结
Industry Perspective on the Medical Risk of Visible Particles in Injectable Drug Products
11天前
已完结
Preclinical studies of the bispecific MUC1xEGFR antibody drug conjugate M1231 in EGFR mutant NSCLC
17天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
18天前
已完结
Exposure–Response Relationships in Patients with Non‐Small‐Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3‐DXd)
18天前
已完结
Characterization, Biomarkers, and Reversibility of a Monoclonal Antibody-induced Immune Complex Disease in Cynomolgus Monkeys (Macaca fascicularis)
1个月前
已完结
Practical Considerations in Determining Adversity and the No-Observed-Adverse-Effect-Level (NOAEL) in Nonclinical Safety Studies: Challenges, Perspectives and Case Studies
2个月前
已完结
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
2个月前
已完结
皖公网安备34019202002308
